4534 — Mochida Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual income statement for Mochida Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	110,179	103,261	102,885	105,159	116,951
Cost of Revenue
Gross Profit	59,553	55,115	52,070	53,788	56,261
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	96,515	94,741	97,415	97,033	106,828
Operating Profit	13,664	8,520	5,470	8,126	10,123
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14,591	9,044	6,160	8,052	11,171
Provision for Income Taxes
Net Income After Taxes	10,569	6,649	4,547	5,685	7,904
Net Income Before Extraordinary Items
Net Income	10,569	6,649	4,547	5,685	7,904
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10,569	6,649	4,547	5,685	7,903
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	291	180	133	161	223
Dividends per Share